Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment
The convergent human immunodeficiency virus (HIV) and tuberculosis (TB) pandemics continue to collectively exact significant morbidity and mortality worldwide. Highly active antiretroviral therapy (HAART) has been a critical component in combating the scourge of these two conditions as both a preem...
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Wiley
2011-01-01
|
| Saila: | Clinical and Developmental Immunology |
| Sarrera elektronikoa: | http://dx.doi.org/10.1155/2011/103917 |